LGALS3 and Sepsis: Further research in animal models has shown that inhibiting Gal3 leads to a significant decrease in the incidence of AKI and mortality in murine models of sepsis and ischemia-reperfusion injury (Sun et al., 2021a; Sun et al., 2021b).